Pericarditis Recurrence Occurs in About 20 Percent of Patients With Lupus

Follow Drugslib on

Medically reviewed by Carmen Pope, BPharm. Last updated on March 4, 2025.

By Elana Gotkine HealthDay Reporter

TUESDAY, March 4, 2025 -- For patients with systemic lupus erythematosus (SLE) and pericarditis, recurrence of pericarditis occurs in more than 20 percent of patients and associated factors include younger age, prednisone treatment, and active SLE disease, according to a study published online Feb. 25 in JAMA Network Open.

Yoo Jin Kim, M.D., from Johns Hopkins University in Baltimore, and colleagues examined the frequency of and risk factors associated with recurrence of pericarditis in patients with SLE in a retrospective analysis of a single-center prospective cohort of patients enrolled between 1988 and 2023.

A total of 2,931 patients were included in the cohort; 590 had a history of pericarditis. The researchers found that 120 patients (20.3 percent) experienced recurrent pericarditis during a median follow-up of 6.7 years and a total of 5,277 years of follow-up. Among patients with recurrence, 50.8 and 49.2 percent experienced only one and two or more recurrences, respectively. Factors associated with recurrence in a multivariable analysis included younger age (60 years and older versus younger than 40 years: rate ratio, 0.11), prednisone treatment (≥20 versus 0 mg: rate ratio, 1.99), active SLE disease (SLE Disease Activity Index ≥3 versus 0: rate ratio, 1.55), and time since initial episode (three to 10 versus <1 year: rate ratio, 0.32).

"Our data suggest that despite the common practice to use prednisone to treat SLE flares, the use of oral corticosteroids should be avoided for patients with a recent history of pericarditis," the authors write.

One author disclosed ties to the pharmaceutical and medical device industries.

Abstract/Full Text

Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.

Source: HealthDay

Posted : 2025-03-05 06:00

Read more

Disclaimer

Every effort has been made to ensure that the information provided by Drugslib.com is accurate, up-to-date, and complete, but no guarantee is made to that effect. Drug information contained herein may be time sensitive. Drugslib.com information has been compiled for use by healthcare practitioners and consumers in the United States and therefore Drugslib.com does not warrant that uses outside of the United States are appropriate, unless specifically indicated otherwise. Drugslib.com's drug information does not endorse drugs, diagnose patients or recommend therapy. Drugslib.com's drug information is an informational resource designed to assist licensed healthcare practitioners in caring for their patients and/or to serve consumers viewing this service as a supplement to, and not a substitute for, the expertise, skill, knowledge and judgment of healthcare practitioners.

The absence of a warning for a given drug or drug combination in no way should be construed to indicate that the drug or drug combination is safe, effective or appropriate for any given patient. Drugslib.com does not assume any responsibility for any aspect of healthcare administered with the aid of information Drugslib.com provides. The information contained herein is not intended to cover all possible uses, directions, precautions, warnings, drug interactions, allergic reactions, or adverse effects. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.

Popular Keywords